NGF and the peptides showed a strong cytotoxic effect on U251 glioma cells in the MTT test (IC<sub>50</sub> 0.0214, 3.1, and 26.1 μM, respectively) compared to chemotherapy. The gene discussed is NGF; the disease is central nervous system cancer.